This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International Europe
27-30 April 2026
Vienna Congress & Convention CenterVienna, Austria
Book Now
Menu
Book Now
Key Sessions
Giancarlo Francese, PhD
A Universal Blueprint for Affordability: Lessons in Formulation and Packaging for Global Health Equity
Gates Foundation
keyboard_arrow_right

Main Conference Day 2 (29th April 2026) - CET/CEST (Cent Europe Summer, GMT+2)

keyboard_arrow_leftSearch & Filter
search
Main Conference Day 2 (29th April 2026) - CET/CEST (Cent Europe Summer, GMT+2)
search
Showing 1 of 1 Streams
08:30 - 08:55
Registration & Morning Coffee
Showing 1 of 1 Streams
08:55 - 09:00
Chairperson's Opening Remarks
09:00 - 09:30KEYNOTE
A Universal Blueprint for Affordability: Lessons in Formulation and Packaging for Global Health Equity
  • Giancarlo Francese, PhD - Senior Program Officer, Gates Foundation
09:30 - 10:00
Keynote Presentation 4
Showing 1 of 1 Streams
10:00 - 10:45
Morning Networking Break in the Exhibit Hall
Showing 5 of 5 Streams
10:45 - 10:50
Chairperson's Opening Remarks
  • Lekan Daramola - Consultant, LD BioConsulting Limited
10:50 - 11:20
Cracking the Bispecific Code: A Multi-Pronged Approach to Chain Pairing and Expression

  • Maximising correct heterodimer assembly by synergy between viral vector engineering & host cell engineering

  • Implementation of advanced analytical strategies in early screening process

  • Enabling clone selection based on quality attributes, not just titre

  • Increasing final yield of correctly formed bi-specific antibody

11:20 - 11:50
Fast-Tracking Implementation of Engineered CHO Host Cell Lines: Directed Evolution of Bioprocess Platforms
  • Preethi Krishnaraj - Post.Doc, Boehringer Ingelheim
11:50 - 12:20
Sponsored Session: Advanced Instruments
10:45 - 10:50
Chairperson's Opening Remarks
10:50 - 11:20
Glycosylation control and reduction of unwanted high-mannose glycans
  • Michael Butler - Principal Investigator, Cell Technology, NIBRT
11:20 - 11:50
Combining data driven and mechanistic models to assist in-silico media optimisation for fed-batch CHO cultures
  • Bhagya Yatipanthalawa - Research Fellow, The University of Melbourne / ARC Digital Bioprocess Development Hub
11:50 - 12:20
Sponsored Session: Thermo Fisher Scientific
10:45 - 10:50
Chairperson's Opening Remarks
10:50 - 11:20
Efficient host cell protein clearance: A study of membrane adsorbers and resins in biopharmaceutical processes
  • Ernest Šprager - Expert Science & Technology, DSPD, Novartis Technical Research & Development
11:20 - 11:50
Beyond Protein A: Building a Non-Affinity Purification Toolbox for the Post-mAb Era
  • Johannes Buyel - Head of Department, BOKU, Austria
11:50 - 12:20
Sponsored Session: Cytiva
10:45 - 10:50
Chairperson's Opening Remarks
10:50 - 11:20
Reconfiguring Biopharmaceutical Manufacturing: Evaluating the Multi-Modal Paradigm
  • A Representative from Biophorum - -, BioPhorum
11:20 - 11:50
Smart bioprocessing by hybrid R&D: enabling scalable CAR-T and stem cell manufacturing
  • Jan Schrooten - CEO, Antleron
11:50 - 12:20
Sponsored Session from JNC
10:45 - 10:50
Chairperson's Opening Remarks
10:50 - 11:20
Beyond the Black Box: Utilising Physics-Informed AI to Build Trustworthy Digital Twins for Bioprocessing

Full Abstract TBC

  • Ignasi Bofarull-Manzano - : Industrial PhD Candidate, Senior CMC Data Scientist and Consultant, RWTH Aachen University
11:20 - 11:50
From In Silico Optimisation to Real-Time Process Control with Hybrid Modelling and PAT Integration
  • Moo Sun Hong - Assistant Professor, Seoul National University
11:50 - 12:20
Sponsored Session: Merck Millipore
Showing 1 of 1 Streams
12:20 - 13:40
Lunch in the Exhibit Hall
Showing 5 of 5 Streams
13:40 - 13:45
Chairperson's Opening Remarks
  • Lekan Daramola - Consultant, LD BioConsulting Limited
13:45 - 14:15
Growing Biologics: Plant-Based Systems as a Scalable, Cost-Effective Alternative

  • Can transient expression in plants provide a method for rapid, scalable production of complex proteins?

  • Overcoming historical challenges associated with plant-based systems:

    • Differences in glycoform patterns

    • Downstream complexities

  • Advantages in scalability, cost, & safety with plant-based systems

14:15 - 14:45
Reimagining Biomanufacturing: Scalable Cell-Free Approaches for Vaccines and Therapeutics
  • Rochelle Aw - Assistant Professor in the School of Life Sciences, University of Nottingham
14:45 - 15:15
Sponsored Session: Pathoquest
13:40 - 13:45
Chairperson's Opening Remarks
13:45 - 14:15
The N-1 Advantage: Supercharging Your Existing Fed-Batch Facility

  • Implementation of N-1 perfusion to reduce production cycle times, improve consistency, and reach higher final titres

  • Inoculating bioreactor at very high cell density

  • Overcoming N-1 perfusion hurdles:

    • Cell retention device selection

    • Process control strategy

  • Developing a robust strategy to implement N-1 perfusion successfully into existing workflows

14:15 - 14:45
Going All In: The Business Case for End-to-End Continuous Manufacturing

  • Can the implementation of an integrated continuous manufacturing process achieve transformative volume of production?

  • Improving final product quality through reduced residence in continuous bioreactor

  • Overcoming high media consumption costs through innovative strategies

  • Dynamic perfusion rate control

  • Media recycling

  • Scalability of continuous facility: factory of the future?

14:45 - 15:15
Sponsored Session: Asahi Kasei
13:40 - 13:45
Chairperson's Opening Remarks
13:45 - 14:15
Magnetic Beads for Cell Separation and Purification: A Scalable, Column-Free Approach
  • Sebastian Schwaminger - Associate Professor, Medical University of Graz
14:15 - 14:45
Resins vs. Membranes vs. Beads: Choosing the Right Tool for the Job

  • Identifying the optimal purification technology for your product

  • Practical framework for choice of ideal technology:

  • Traditional columns

  • Membrane

  • Magnetic based system

  • Roadmap for implementing new technologies into workflow

14:45 - 15:15
Reduce bottlenecks and gain efficiency through innovation in buffer preparation and management
  • Shannon J. Ryan, Ph.D - Senior Director, Application Services, Avantor
13:40 - 13:45
Chairperson's Opening Remarks
13:45 - 14:15
From Open Bench to Closed System: Cell Therapy Manufacturing
  • Subash Ramamoorthy - Principal Automation & Robotics, Bayer AG
14:15 - 14:45
Industrializing 'Off-the-Shelf' Therapies: Scaling Stem Cell-Derived Cell Therapy Manufacturing
  • Volker Huppert - Chief Development Officer, Glycostem Therapeutics
14:45 - 15:15
Sponsored Session: Merck Millipore
13:40 - 13:45
Chairperson's Opening Remarks
13:45 - 14:15
A First-Principles based Framework for Risk Reduction in scale-up and transfer of Bioprocesses
  • Christian Witz - CEO, SimVantage GmbH
14:15 - 14:45
CASE STUDY: Implementing In-Line PAT for Real-Time Process Control
  • A Representative from Johnson & Johnson Innovative Medicine - (Pending Final Confirmation), Johnson & Johnson Innovative Medicine
14:45 - 15:15
Sponsored Session: ArgusEye AB
Showing 1 of 1 Streams
15:15 - 16:00
Afternoon Break in the Exhibit Hall
Showing 5 of 5 Streams
16:00 - 16:30
The AAV Holy Grail: Building a Stable, Scalable Producer Cell Line

  • Overcoming the limitations of industry-standard triple-transient transfection for large scale AAV manufacturing:

  • Cost, scalability, batch to batch variability

  • Developing a stable, suspension-adapted inducible producer cell line (e.g. HEK293 or CHO-based host)

  • Vector design, clone selection, process optimisation

  • Improving full-to-empty capsid ratio and process scalability with innovative CLD approaches

16:30 - 17:00
Taming the Bioreactor: Process Development for Scaling Stable AAV Producer Lines

  • Optimising critical process parameters (CPPs) such as media composition, feed strategy, etc. for maximal vector yield

  • Characterising impact of bioreactor shear stress on cell health and viral particle quality

  • Process comparability and scalability from bench-scale to pilot-scale single-use bioreactors

16:00 - 16:30
The Clarification Bottleneck: Novel Filtration and Centrifugation Strategies for High-Density Cell Cultures
  • Stefano Menegatti - Professor, Chemical and Biomolecular Engineering, NC State University, North Carolina State University
16:30 - 17:00
PANEL DISCUSSION: Harmonising the Handshake: Improving the USP-DSP Interface
  • Gearóid Duane - Senior Principal Scientist, Bristol Myers Squibb, Cruiserath Biologics
16:00 - 16:30
The Clarification Bottleneck: Novel Filtration and Centrifugation Strategies for High-Density Cell Cultures
  • Stefano Menegatti - Professor, Chemical and Biomolecular Engineering, NC State University, North Carolina State University
16:30 - 17:00
PANEL DISCUSSION: Harmonising the Handshake: Improving the USP-DSP Interface
  • Gearóid Duane - Senior Principal Scientist, Bristol Myers Squibb, Cruiserath Biologics
16:00 - 16:30
An Automated Controlled Bioreactor Platform for Scalable 3D Expansion of induced Pluripotent Stem Cells
  • Andy Wiranata Wijaya - Bioprocess Development Lead, Nestlé Product Technology Center
16:30 - 17:00
PANEL DISCUSSION: The Platform Wars - The Future of Autologous, Allogeneic, and In Vivo Modalities
  • Terri Gaskell (Pending Final Confirmation) - CTO, Rinri Therapeutics
16:00 - 17:00
PANEL DISCUSSION: Closing the Digital Skills Gap

  • The ‘smart factory’ requires a smart workforce

  • Overcoming the digital skills gap in biomanufacturing:

    • Effective training strategies

    • Role of VR in operator training

    • Building a culture of continuous learning

    • Upskilling existing teams

  • Overall supporting digital transformation

  • Steven Fuller - Founder & Director, Race in STEM
  • Jason Beckwith, PhD DBA MBA - SVP Talent Science & Thought Leadership, BioTalent
17:00 - 19:00
Offsite Networking Party
Main Conference Day 1 (28th April 2026)
NextMain Conference Day 3 (30th April 2026)
Filter
Streams
Choose Day